208 related articles for article (PubMed ID: 23889217)
1. DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function.
Fusi FM; Ferrario M; Bosisio C; Arnoldi M; Zanga L
Gynecol Endocrinol; 2013 Oct; 29(10):940-3. PubMed ID: 23889217
[TBL] [Abstract][Full Text] [Related]
2. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.
Weghofer A; Kim A; Barad DH; Gleicher N
Hum Reprod; 2012 Nov; 27(11):3287-93. PubMed ID: 22811313
[TBL] [Abstract][Full Text] [Related]
3. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
[TBL] [Abstract][Full Text] [Related]
5. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
[TBL] [Abstract][Full Text] [Related]
6. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Barad D; Brill H; Gleicher N
J Assist Reprod Genet; 2007 Dec; 24(12):629-34. PubMed ID: 18071895
[TBL] [Abstract][Full Text] [Related]
7. Effect of dehydroepiandrosterone administration in Chinese women over 37 years undergoing assisted reproductive techniques.
Liu X; Wang W; Wang X; Qu Q; Hao C
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():9-13. PubMed ID: 27156150
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels.
Weissman A; Horowitz E; Ravhon A; Golan A; Levran D
Gynecol Endocrinol; 2011 Dec; 27(12):1014-7. PubMed ID: 21500990
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
11. Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review.
Tsui KH; Lin LT; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):131-6. PubMed ID: 25951716
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
[TBL] [Abstract][Full Text] [Related]
14. The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis.
Qin JC; Fan L; Qin AP
J Gynecol Obstet Hum Reprod; 2017 Jan; 46(1):1-7. PubMed ID: 28403950
[TBL] [Abstract][Full Text] [Related]
15. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study.
Wiser A; Gonen O; Ghetler Y; Shavit T; Berkovitz A; Shulman A
Hum Reprod; 2010 Oct; 25(10):2496-500. PubMed ID: 20729538
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old.
Tartagni M; Cicinelli MV; Baldini D; Tartagni MV; Alrasheed H; DeSalvia MA; Loverro G; Montagnani M
Reprod Biol Endocrinol; 2015 Mar; 13():18. PubMed ID: 25884390
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders.
Triantafyllidou O; Sigalos G; Vlahos N
Hum Fertil (Camb); 2017 Jun; 20(2):80-87. PubMed ID: 27927044
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection.
Li J; Yuan H; Chen Y; Wu H; Wu H; Li L
Int J Gynaecol Obstet; 2015 Dec; 131(3):240-5. PubMed ID: 26421833
[TBL] [Abstract][Full Text] [Related]
19. DHEA supplementation improves follicular microenviroment in poor responder patients.
Artini PG; Simi G; Ruggiero M; Pinelli S; Di Berardino OM; Papini F; Papini S; Monteleone P; Cela V
Gynecol Endocrinol; 2012 Sep; 28(9):669-73. PubMed ID: 22835219
[TBL] [Abstract][Full Text] [Related]
20. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.
Gleicher N; Ryan E; Weghofer A; Blanco-Mejia S; Barad DH
Reprod Biol Endocrinol; 2009 Oct; 7():108. PubMed ID: 19811650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
